{
    "id": "5c9906dcecadf2e73f00002f",
    "question": "Are cardenolides inhibitors of Na+/K+ ATPase?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, let's analyze the given documents and the question itself. Cardenolides are a class of drugs that are known to have a specific mechanism of action. The question asks if cardenolides inhibit Na+/K+ ATPase. From Document [23], we can see that cardenolides, such as digoxin, directly inhibit Na+/K+ ATPase. This suggests that the correct answer is A. yes. However, let's also consider the definition of cardenolides from Document [23] and the mechanism of action described in the question. Cardenolides are a class of compounds that include digoxin, and they inhibit the Na+/K+ ATPase enzyme. This enzyme is responsible for maintaining the gradient of Na+ and K+ across the plasma membrane, which is essential for various cellular functions. The inhibition of Na+/K+ ATPase by cardenolides leads to increased intracellular sodium levels, which in turn increases the contractility of the heart. Additionally, cardenolides can also inhibit the Na+/Ca2+ exchanger, which further enhances the contractile force of the heart. Therefore, the answer to the question is A. yes, cardenolides are inhibitors of Na+/K+ ATPase.\"} {\"answer_choice\": \"A\"}",
    "snippets": [
        {
            "id": "Pharmacology_Katzung_1255",
            "title": "Pharmacology_Katzung",
            "content": "F. Intracellular Sodium Concentration and Activity of Na+/K+-ATPase Na+/K+-ATPase, by removing intracellular sodium, is the major determinant of sodium concentration in the cell. The sodium"
        },
        {
            "id": "Pharmacology_Katzung_1276",
            "title": "Pharmacology_Katzung",
            "content": "At the molecular level, all therapeutically useful cardiac glycosides inhibit Na+/K+-ATPase, the membrane-bound transporter often called the sodium pump (Figure 13\u20131). Although several isoforms of this ATPase occur and have varying sensitivity to cardiac glycosides, they are highly conserved in evolution. Inhibition of this transporter over most of the dose range has been extensively documented in all tissues studied. It is probable that this inhibitory action is largely responsible for the therapeutic effect (positive inotropy) as well as a major portion of the toxicity of digitalis. Other molecular-level effects of digitalis have been studied in the heart and are discussed below. The fact that a receptor for cardiac glycosides exists on the sodium pump has prompted some investigators to propose that an endogenous digitalis-like steroid, possibly ouabain or marinobufagenin, must exist. Furthermore, additional functions of Na+/K+-ATPase have been postulated, involving apoptosis, cell"
        },
        {
            "id": "Pharmacology_Katzung_1501",
            "title": "Pharmacology_Katzung",
            "content": "K channels,1 H+ trans-Adenosine antagonists porter,1 aquaporins (under investigation) 1Not a target of currently available drugs. 2Controlled by vasopressin activity. FIGURE 15\u20132 Apical membrane Na+/H+ exchange (via NHE3) and bicarbonate reabsorption in the proximal convoluted tubule cell. Na+/K+-ATPase is present in the basolateral membrane to maintain intracellular sodium and potassium levels within the normal range. Because of rapid equilibration, concentrations of the solutes are approximately equal in the interstitial fluid and the blood. Carbonic anhydrase (CA) is found in other locations in addition to the brush border of the luminal membrane. SGLT2, Na+/glucose transporter. can be inhibited by acetazolamide and other carbonic anhydrase inhibitors."
        },
        {
            "id": "First_Aid_Step1_23",
            "title": "First_Aid_Step1",
            "content": "nasal nitric oxide (used as screening test). (Kartagener\u2019s restaurant: take-out only; there\u2019s no dynein \u201cdine-in\u201d.) Na+-K+ ATPase is located in the plasma membrane with ATP site on cytosolic side. For each ATP consumed, 3 Na+ leave the cell (pump phosphorylated) and 2 K+ enter the cell (pump dephosphorylated). Plasma membrane is an asymmetric lipid bilayer containing cholesterol, phospholipids, sphingolipids, glycolipids, and proteins. Pumpkin = pump K+ in. Ouabain (a cardiac glycoside) inhibits by binding to K+ site. Cardiac glycosides (digoxin and digitoxin) directly inhibit the Na+-K+ ATPase, which leads to indirect inhibition of Na+/Ca2+ exchange \u008e\u2022 [Ca2+]i \u008e\u008f cardiac contractility. Cleavage of procollagen Cand N-terminals Formation of cross-links (stabilized by lysyl oxidase) Collagen fber"
        },
        {
            "id": "Pharmacology_Katzung_1347",
            "title": "Pharmacology_Katzung",
            "content": "Na+/K+-ATPase NKAIN1-4/Na, K-pump FIGURE 14\u20132 Schematic diagram of the ion permeability changes and transport processes that occur during an action potential and the diastolic period following it. Yellow indicates inward (depolarizing) membrane currents; blue indicates outward (repolarizing) membrane currents. Multiple subtypes of potassium and calcium currents, with different sensitivities to blocking drugs, have been identified. The right side of the figure lists the genes and proteins responsible for each type of channel or transporter."
        },
        {
            "id": "Pharmacology_Katzung_1515",
            "title": "Pharmacology_Katzung",
            "content": "potential is increased, and K+ secretion is enhanced. This mechanism, combined with enhanced aldosterone secretion due to volume depletion, is the basis for most diuretic-induced K+ wasting. Reabsorption of Na+ via the epithelial Na channel (ENaC) and its coupled secretion of K+ are regulated by aldosterone. This steroid hormone, through its actions on gene transcription, increases the activity of both the apical membrane channels and the basolateral Na+/K+-ATPase. This leads to an increase in the transepithelial electrical potential and a dramatic increase in both Na+ reabsorption and K+ secretion."
        },
        {
            "id": "Pharmacology_Katzung_1497",
            "title": "Pharmacology_Katzung",
            "content": "Of the various solutes reabsorbed in the proximal tubule, the most relevant to diuretic action are NaHCO3 and NaCl. Until recently, of the currently available diuretics, only one group (carbonic anhydrase inhibitors, which block NaHCO3 reabsorption) has acted predominantly in the PCT. Sodium bicarbonate reabsorption by the PCT is initiated by the action of a Na+/ exchanger (NHE3) located in the luminal membrane of the proximal tubule epithelial cell (Figure 15\u20132). This transport system allows Na+ to enter the cell from the tubular lumen in exchange for a proton (H+) from inside the cell. As in all portions of the nephron, Na+/K+-ATPase in the basolateral membrane pumps the reabsorbed Na+ into the interstitium in order to maintain a low intracellular Na+ concentration. The H+ secreted into the lumen combines with bicarbonate (HCO3\u2212) to form H2CO3 (carbonic acid), which is rapidly dehydrated to CO2 and H2O by carbonic anhydrase. Carbon dioxide produced by dehydration of H2CO3 enters the"
        },
        {
            "id": "Physiology_Levy_1804",
            "title": "Physiology_Levy",
            "content": "Fig. 13.2 ). For example, reducing extracellular [Na+] causes less Na+ to enter the cell in exchange for Ca++ , which results in an increase in intracellular [Ca++] and thus contractile force. Raising intracellular [Na+] has a similar effect. In fact, this is the mechanism by which cardiac glycosides increase contractile force. Cardiac glycosides inhibit Na+,K+-ATPase and thereby raise intracellular [Na+] in the cells. The elevated cytosolic [Na+] reverses the direction of the 3Na+-Ca++ antiporter, and therefore less Ca++ is removed from the cell. The increase in intracellular [Ca++] results in an increase in contractile force. Finally, contractile force is diminished when intracellular [Ca++] is decreased by a reduction in extracellular [Ca++], by an increase in the Na+ gradient across the sarcolemma, or by the administration of a calcium channel antagonist that prevents Ca++ from entering the myocardial cell."
        },
        {
            "id": "Cell_Biology_Alberts_2990",
            "title": "Cell_Biology_Alberts",
            "content": "J.V. M\u00f8ller et al., Q. Rev. Biophys. 43:501\u2013 566, 2010.) Figure 11\u201315 The function of the Na+-K+ pump. This P-type ATPase actively pumps Na+ out of and K+ into a cell against their electrochemical gradients. It is structurally closely related to the Ca2+ ATPase but differs in its selectivity for ions: for every molecule of ATP hydrolyzed by the pump, three Na+ are pumped out and two K+ are pumped in. As in the Ca2+ pump, an aspartate is phosphorylated and dephosphorylated during the pumping cycle (Movie 11.4). ABC Transporters Constitute the Largest Family of Membrane Transport Proteins"
        },
        {
            "id": "Pharmacology_Katzung_3195",
            "title": "Pharmacology_Katzung",
            "content": "A. Effects on Electrolytes and Ion Transport Lithium is closely related to sodium in its properties. It can substitute for sodium in generating action potentials and in Na+-Na+ exchange across the membrane. At therapeutic concentrations (~1 mEq/L), it does not significantly affect the Na+-Ca2+ exchanger or the Na+/K+-ATPase pump. B. Effects on Second Messengers"
        },
        {
            "id": "Cell_Biology_Alberts_2986",
            "title": "Cell_Biology_Alberts",
            "content": "The Plasma Membrane Na+-K+ Pump Establishes Na+ and K+ Gradients Across the Plasma Membrane The concentration of K+ is typically 10\u201330 times higher inside cells than outside, whereas the reverse is true of Na+ (see Table 11\u20131, p. 598). A Na+-K+ pump, or Na+K+ ATPase, found in the plasma membrane of virtually all animal cells maintains"
        },
        {
            "id": "Physiology_Levy_186",
            "title": "Physiology_Levy",
            "content": "As noted previously, the Na+,K+-ATPase and K+-selective channels play an important role in establishing cellular ion gradients for Na+ and K+ and in generating the Vm. In all epithelial cells except the choroid plexus and retinal pigment epithelium, the Na+,K+-ATPase channel is located in the basolateral membrane of the cell. Numerous K+selective channels are in epithelial cells and may be located in either membrane domain. Through the establishment of these chemical and voltage gradients, the transport of other ions and solutes can be driven (e.g., Na+-glucose symporter, Na+-H+ antiporter, 1Na+,1K+,2Cl\u2212 symporter, 1Na+-3HCO3 \u2212 symporter). The direction of transepithelial transport (reabsorption or secretion) depends simply on which membrane domain the transporters are located. Because of the dependence on the Na+,K+-ATPase, epithelial transport requires the expenditure of energy. Other ATP-dependent transporters, such as the H+-ATPase, H+,K+-ATPase, and a host of ABC"
        },
        {
            "id": "Pharmacology_Katzung_1513",
            "title": "Pharmacology_Katzung",
            "content": "into the principal cell predominates over K+ secretion into the lumen, a 10\u201350 mV lumen-negative electrical potential develops. Sodium that enters the principal cell from the tubular fluid is then transported back to the blood via the basolateral Na+/K+-ATPase (Figure 15\u20135). The 10\u201350 mV lumen-negative electrical potential drives the transport of Cl\u2212 back to the blood via the paracellular pathway and draws K+ out of cells through the apical membrane K+ channel. Thus, there is an important relationship between Na+ delivery to the collecting tubule system and the resulting secretion of K+. Upstream diuretics increase Na+ delivery to this site and enhance K+ secretion. If Na+ is delivered to the collecting system with an anion that cannot be reabsorbed as readily as Cl\u2212 (eg, HCO3\u2212), the lumen-negative"
        },
        {
            "id": "Pharmacology_Katzung_1512",
            "title": "Pharmacology_Katzung",
            "content": "The mechanism of NaCl reabsorption in the collecting tubule system is distinct from the mechanisms found in other tubule segments. The principal cells are the major sites of Na+, K+, and water transport (Figures 15\u20135 and 15\u20136), and the intercalated cells (\u03b1, \u03b2) are the primary sites of H+ (\u03b1 cells) or bicarbonate (\u03b2 cells) secretion. The \u03b1 and \u03b2 intercalated cells are very similar, except that the membrane locations of the H+-ATPase and Cl\u2212/ HCO3\u2212 exchanger are reversed. Principal cells do not contain apical cotransport systems for Na+ and other ions, unlike cells in other nephron segments. Principal cell membranes exhibit separate ion channels for Na+ and K+. Since these channels exclude anions, transport of Na+ or K+ leads to a net movement of charge across the membrane. Because Na+ entry into the principal cell predominates over K+ secretion into the lumen, a 10\u201350 mV lumen-negative electrical potential develops. Sodium that enters the principal cell from the tubular fluid is then"
        },
        {
            "id": "Physiology_Levy_156",
            "title": "Physiology_Levy",
            "content": "The importance of the Na+,K+-ATPase in isotonic cell volume regulation can be appreciated by the observation that red blood cells swell when chilled (i.e., reduced ATP synthesis) or when the Na+,K+-ATPase is inhibited by cardiac glycosides (e.g., ouabain, digoxin [Lanoxin]). The necessity for energy expenditure to maintain cell volume in an isotonic solution is the result of the effect of intracellular proteins on the distribution of ions across the plasma membrane: the so-called Gibbs-Donnan effect ( Fig. 2.6"
        },
        {
            "id": "Pharmacology_Katzung_1559",
            "title": "Pharmacology_Katzung",
            "content": "Excessive use of any diuretic is dangerous in patients with hepatic cirrhosis, borderline renal failure, or heart failure (see text that follows). Potassium-sparing diuretics prevent K+ secretion by antagonizing the effects of aldosterone in collecting tubules. Inhibition may occur by direct pharmacologic antagonism of mineralocorticoid receptors (spironolactone, eplerenone) or by inhibition of Na+ influx through ion channels in the luminal membrane (amiloride, triamterene). Finally, ularitide (recombinant urodilatin), which is currently still under investigation, blunts Na+ uptake and Na+/K+-ATPase in collecting tubules and increases GFR through its vascular effects. Nesiritide, which is available for intravenous use only, increases GFR and blunts Na+ reabsorption in both proximal and collecting tubules. The structures of spironolactone and amiloride are shown in Figure 15\u20139."
        },
        {
            "id": "InternalMed_Harrison_21423",
            "title": "InternalMed_Harrison",
            "content": "Principal cells secrete K+ through an apical membrane potassium channel. Several forces govern the secretion of K+. Most importantly, the high intracellular K+ concentration generated by Na+/K+-ATPase creates a favorable concentration gradient for K+ secretion into tubular fluid. With reabsorption of Na+ without an accompanying anion, the tubular lumen becomes negative relative to the cell interior, creating a favorable electrical gradient for secretion of potassium. When Na+ reabsorption is blocked, the electrical component of the driving force for K+ secretion is blunted, and this explains lack of excess urinary K+ loss during treatment with potassium-sparing diuretics or mineralocorticoid receptor antagonists. K+ secretion is also promoted by aldosterone actions that increase regional Na+ transport favoring more electronegativity and by increasing the number and activity of potassium channels. Fast tubular fluid flow rates that occur during volume expansion or diuretics acting"
        },
        {
            "id": "Pharmacology_Katzung_1341",
            "title": "Pharmacology_Katzung",
            "content": "Ionic Basis of Membrane Electrical Activity The electrical excitability of cardiac cells is a function of the unequal distribution of ions across the plasma membrane\u2014chiefly sodium (Na+), potassium (K+), calcium (Ca2+), and chloride (Cl\u2212)\u2014and the relative permeability of the membrane to each ion. The gradients are generated by transport mechanisms that move these ions across the membrane against their concentration gradients. The most important of these transport mechanisms is the Na+/K+-ATPase, or sodium pump, described in Chapter 13. It is responsible for keeping the intracellular sodium concentration low and the intracellular potassium concentration high relative to their respective extracellular concentrations. Other transport mechanisms maintain the gradients for calcium and chloride."
        },
        {
            "id": "Pharmacology_Katzung_1258",
            "title": "Pharmacology_Katzung",
            "content": "influx through voltage-gated channels, which occurs as a normal part of almost all cardiac action potentials, is another determinant, although the amount of sodium that enters with each action potential is much less than 1% of the total intracellular sodium. Na+/K+-ATPase appears to be the primary target of digoxin and other cardiac glycosides. Pathophysiology of Heart Failure"
        },
        {
            "id": "Pharmacology_Katzung_1256",
            "title": "Pharmacology_Katzung",
            "content": "FIGURE 13\u20131 Schematic diagram of a cardiac muscle sarcomere, with sites of action of several drugs that alter contractility. (Mitochondria, which are critical for the generation of ATP, are omitted for simplicity.) Na+/K+-ATPase, the sodium pump, is the site of action of cardiac glycosides. NCX is the sodium-calcium exchanger. Cav-L is the voltage-gated, L-type calcium channel. SERCA (sarcoplasmic endoplasmic reticulum Ca2+-ATPase) is a calcium transporter ATPase that pumps calcium into the sarcoplasmic reticulum. CalS is calcium bound to calsequestrin, a high-capacity Ca2+-binding protein. RyR (ryanodine RyR2 receptor) is a calcium-activated calcium channel in the membrane of the SR that is triggered to release stored calcium. Z is the Z-line, which delimits the sarcomere. Calcium sensitizers act at the actin-troponin-tropomyosin complex where activator calcium brings about the contractile interaction of actin and myosin. Black arrows represent processes that initiate contraction or"
        },
        {
            "id": "Physiology_Levy_1722",
            "title": "Physiology_Levy",
            "content": "Overdrive suppression results from the activity of membrane Na+,K+-ATPase. A certain amount of Na+ enters the cardiac cell during each depolarization. The more frequently the cell is depolarized, the more Na+ enters the cell per minute. At high excitation frequencies, the activity of Na+,K+-ATPase increases to extrude this larger amount of Na+ from the cell. The activity of Na+,K+-ATPase hyperpolarizes the cell because three Na+ ions are extruded by the pump in exchange for two K+ ions that enter the cell (see ). Therefore, slow diastolic depolarization requires more time to reach the firing threshold. In addition, when the overdrive suddenly ceases, the activity of Na+,K+-ATPase does not slow instantaneously but temporarily remains overactive. This continued extrusion of Na+ opposes the gradual depolarization of the pacemaker cell during phase 4, and it temporarily suppresses the cell\u2019s intrinsic automaticity."
        },
        {
            "id": "Physiology_Levy_3571",
            "title": "Physiology_Levy",
            "content": "K+ K+ \u00b0 Flow stimulates Na+ entry, which reduces Vm \u00b0 Flow Cilia bend activates PKD1/PKD2 and Ca++ entry \u00b0 Flow bends cilia \u00b0 Ca++ activates Na+ Ca++ ATP 1 25 4 3 \u2022 Fig. 36.9 Cellular mechanism whereby an increased flow rate of tubule fluid stimulates secretion of K+ by principal cells. See text for details. interior negative membrane potential. This depolarization of the cell membrane potential increases the electrochemical driving force that promotes secretion of K+ across the apical cell membrane into tubule fluid. In addition, increased uptake of Na+ into cells activates the Na+,K+-ATPase in the basolateral membrane, thereby increasing uptake of K+ across the basolateral membrane and consequently elevating [K+]. However, it is important to note that an increase in flow rate during a water diuresis does not have a significant effect on excretion of K+ , most likely because during a water diuresis the [Na+] of tubule fluid does not increase as flow rises."
        },
        {
            "id": "Surgery_Schwartz_8067",
            "title": "Surgery_Schwartz",
            "content": "bilayer, cotransport with other ions and nutrients, or diffusion through water channels called aquaporins. Many different types of aquaporins have been identified; however, their contribution to overall intestinal water absorption appears to be relatively minor.5The prevailing model for intestinal epithelial Na+ absorp-tion is shown in Fig. 28-5. Activity of the Na+/K+ ATPase enzyme, which is located in the basolateral membrane and exchanges three intracellular Na+ for every two extracellular K+ in an energy-dependent process, generates the electrochemi-cal gradient that drives the transport of Na+ from the intestinal lumen into the cytoplasm of enterocytes. Na+ ions traverse the apical membrane through several distinct transporter mecha-nisms, including nutrient-coupled sodium transport (e.g., sodium glucose cotransporter-1, SGLT1), sodium channels, and sodium-hydrogen exchangers (NHEs). Absorbed Na+ ions are then extruded from enterocytes through the Na+/K+ ATPase located in the"
        },
        {
            "id": "First_Aid_Step1_334",
            "title": "First_Aid_Step1",
            "content": "Cardiac glycosides Digoxin. MECHANISM Direct inhibition of Na+/K+ ATPase inhibition of Na+/Ca2+ exchanger. [Ca2+]i \u2022 positive inotropy. Stimulates vagus nerve \u008e\u0090 HR. ClINICAl uSE HF (\u008f contractility); atrial fibrillation (\u0090 conduction at AV node and depression of SA node). AdvERSE EFFECTS Cholinergic effects (nausea, vomiting, diarrhea), blurry yellow vision (think van Glow), arrhythmias, AV block. Can lead to hyperkalemia, which indicates poor prognosis. Factors predisposing to toxicity: renal failure (\u0090 excretion), hypokalemia (permissive for digoxin binding at K+-binding site on Na+/K+ ATPase), drugs that displace digoxin from tissue-binding sites, and \u0090 clearance (eg, verapamil, amiodarone, quinidine). ANTIdOTE Slowly normalize K+, cardiac pacer, anti-digoxin Fab fragments, Mg2+."
        },
        {
            "id": "Physiology_Levy_3558",
            "title": "Physiology_Levy",
            "content": "Box 36.2 Plasma [K+] is an important determinant of K+ secretion by the distal tubule and collecting duct. Hyperkalemia (e.g., resulting from a high-K+ diet or from rhabdomyolysis) Fig. 36.6 Cellular mechanism of K+ secretion by principal cells. The numbers indicate where K+ secretion is regulated. 1, Na+,K+-ATPase; 2, electrochemical gradient of K+ across the apical membrane; 3, permeability of the apical membrane to K+ . Fig. 36.7 Effects of aldosterone on secretion of K+ by principal cells in the late segment of the distal tubule and collecting duct. Numbers refer to the five effects of aldosterone discussed in text. K+ K+ \u02dc K+ permeability + \u02dc CAP \u02dc SGK\u02dc ENaC \u02dcNa+,K+-ATPase + + Na+ ATP 2 1 3 4 5 IN THE CLINIC \u2022 BOX 36.2 Major Factors and Hormones Influencing K+Excretion Physiological: Keep K+ Balance Constant Pathophysiological: Displace K+ Balance"
        },
        {
            "id": "Pharmacology_Katzung_1328",
            "title": "Pharmacology_Katzung",
            "content": "Elkayam U et al: Vasodilators in the management of acute heart failure. Crit Care Med 2008;36:S95. Fitchett DH, Udell JA, Inzucchi SE: Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetes. Eur J Heart Fail 2017;19:43. George M et al: Novel drug targets in clinical development for heart failure. Eur J Clin Pharmacol 2014;70:765. Givertz MM et al: Acute decompensated heart failure: Update on new and emerging evidence and directions for future research. J Card Fail 2013;19:371. Hasenfuss G, Teerlink JR: Cardiac inotropes: Current agents and future directions. Eur Heart J 2011;32:1838. Lam GK et al: Digoxin antibody fragment, antigen binding (Fab), treatment of preeclampsia in women with endogenous digitalis-like factor: A secondary analysis of the DEEP Trial. Am J Obstet Gynecol 2013;209:119. Lingrel JB: The physiological significance of the cardiotonic steroid/ouabainbinding site of the Na, K-ATPase. Annu Rev Physiol 2010;72:395."
        },
        {
            "id": "InternalMed_Harrison_28398",
            "title": "InternalMed_Harrison",
            "content": "Several genetic magnesium-wasting syndromes have been described, including inactivating mutations of genes encoding the DCT NaCl co-transporter (Gitelman\u2019s syndrome), proteins required for cTAL Na-K-2Cl transport (Bartter\u2019s syndrome), claudin 16 or claudin 19 (autosomal recessive renal hypomagnesemia with hypercalciuria), a DCT Na+,K+-ATPase \u03b3-subunit (autosomal dominant renal hypomagnesemia with hypocalciuria), DCT K+ channels (Kv1.1, Kir4.1), and a mitochondrial gene encoding a tRNA. Activating mutations CAuSES of HyPomAgnESEmiA I. Impaired intestinal absorption A. Hypomagnesemia with secondary hypocalcemia (TRPM6 mutations) B. Malabsorption syndromes C. Vitamin D deficiency D. Proton pump inhibitors II. A. B. Intestinal drainage, fistulas III. A. 1. 2. 3. 4. Potassium channel mutations (Kv1.1, Kir4.1) 5. Na+,K+-ATPase \u03b3-subunit mutations (FXYD2) B. Acquired renal disease 1. 2. Postobstruction, ATN (diuretic phase) 3. C. Drugs and toxins 1. 2."
        },
        {
            "id": "Physiology_Levy_40",
            "title": "Physiology_Levy",
            "content": "Na+,K+-ATPase(alsocalledtheNa+,K+-pump orjusttheNa+pump)isfoundinallcellsandisresponsibleforestablishingthegradientsofNa+ andK+ acrosstheplasmamembrane.Thesegradientsinturnprovideenergyforseveralessentialcellfunctions(see ).Na+,K+-ATPaseiscomposedofthreesubunits(\u03b1,\u03b2,and\u03b3),andtheproteinexistsinthemembranewithastoichiometriccompositionof1\u03b1,1\u03b2,1\u03b3.The\u03b1 subunitcontainsbindingsitesforNa+,K+ andATP.Itisalsothesubunitthatbindscardiacglycosides(e.g.,ouabain),whichspecificallyinhibittheenzyme.Ithasatransmembranedomainandthreeintracellulardomains:phosphorylation(P-domain),nucleotidebinding(N-domain),andactuator(A-domain).Althoughthe\u03b1 subunitisthefunctionalsubunitoftheenzyme(i.e.,ithydrolyzesATP,bindsNa+ andK+ ,andtranslocatesthemacrossthemembrane),itcannotfunctionwithoutthe\u03b2 subunit.The\u03b2 subunitisresponsiblefortargetingthe\u03b1 subunittothemembraneandalsoappearstomodulatetheaffinityoftheNa+,K+-ATPaseforNa+ andK+ .The\u03b1 and\u03b2 subunitscancarryoutNa+ andK+ transportintheabsenceofthe\u03b3 subunit.However,the\u03b3"
        },
        {
            "id": "Physiology_Levy_140",
            "title": "Physiology_Levy",
            "content": "is that the cellular K+ gradient generated by the activity of the Na+,K+-ATPase is a major determinant of the membrane voltage because of the leak of K+ out of the cell through K+selective channels (see the section \u201c"
        },
        {
            "id": "Pharmacology_Katzung_308",
            "title": "Pharmacology_Katzung",
            "content": "Disease states can affect both of the physiologically related primary pharmacokinetic parameters: volume of distribution and clearance. A change in half-life will not necessarily reflect a change in drug elimination. For example, patients with chronic renal failure have both decreased renal clearance of digoxin and a decreased volume of distribution; the increase in digoxin half-life is not as great as might be expected based on the change in renal function. The decrease in volume of distribution is due to the decreased renal and skeletal muscle mass and consequent decreased tissue binding of digoxin to Na+/K+-ATPase. Many drugs will exhibit multicompartment pharmacokinetics (as illustrated in Figures 3\u20132C and 3\u20132D). Under these conditions, the \u201chalf-life\u201d reflecting drug accumulation, as given in Table 3\u20131, will be greater than that calculated from equation (6)."
        },
        {
            "id": "First_Aid_Step1_333",
            "title": "First_Aid_Step1",
            "content": "Verapamil is similar to \u03b2-blockers in effect. Pindolol and acebutolol are partial \u03b2-agonists that should be used with caution in angina. MECHANISM Inhibits the late phase of inward sodium current thereby reducing diastolic wall tension and oxygen consumption. Does not affect heart rate or blood pressure. ClINICAl uSE Angina refractory to other medical therapies. AdvERSE EFFECTS Constipation, dizziness, headache, nausea. MECHANISM A neprilysin inhibitor; prevents degradation of natriuretic peptides, angiotensin II, and substance P \u008e\u008f vasodilation, \u0090 ECF volume. ClINICAl uSE Used in combination with valsartan (an ARB) to treat HFrEF. AdvERSE EFFECTS Hypotension, hyperkalemia, cough, dizziness; contraindicated with ACE inhibitors due to angioedema. Cardiac glycosides Digoxin. MECHANISM Direct inhibition of Na+/K+ ATPase inhibition of Na+/Ca2+ exchanger. [Ca2+]i \u2022 positive inotropy. Stimulates vagus nerve \u008e\u0090 HR."
        },
        {
            "id": "Pharmacology_Katzung_1325",
            "title": "Pharmacology_Katzung",
            "content": "Candesartan, valsartan, many other ARBs: Like losartan Chronic heart failure: To slow failure \u2022 many other indications in Chapter 10 Oral \u2022 duration 10\u201312 h \u2022 Toxicity: Bronchospasm, bradycardia, atrioventricular block, acute \u2022 Metoprolol, bisoprolol, nebivolol: Select group of b blockers that have been shown to reduce heart failure mortality \u2022Digoxin(otherglycosides are used outside the USA) Na+/K+-ATPase inhibition results in reduced Ca2+ expulsion and increased Ca2+ stored in sarcoplasmic reticulum Increases cardiac contractility \u2022cardiacparasympathomimeticeffect (slowed sinus heart rate, slowed atrioventricular conduction) Chronic symptomatic heart failure\u2022rapidventricularrateinatrialfibrillation\u2022hasnotbeen shown to reduce mortality but does reduce rehospitalization Oral,parenteral\u2022duration36\u201340h\u2022Toxicity: Nausea, vomiting,diarrhea\u2022cardiacarrhythmias CARDIAC GLYCOSIDE Enalapril Generic, Vasotec, Vasotec I.V. Fosinopril Generic, Monopril Lisinopril Generic, Prinivil, Zestril"
        }
    ],
    "scores": [
        0.03391669935787583,
        0.03131280572274643,
        0.027199725872292243,
        0.025648411430545186,
        0.024399505753096913,
        0.023870822041553753,
        0.023581757508342602,
        0.023151515151515152,
        0.02313511908089376,
        0.022429613996363115,
        0.02207636229254855,
        0.021913977111996913,
        0.0213155364805677,
        0.021032772966547802,
        0.021005887170130414,
        0.02082360914662895,
        0.020510419673856674,
        0.019341424620927725,
        0.018329427519250083,
        0.017304393227418516,
        0.016998166172943998,
        0.0166052895882156,
        0.016359508547008548,
        0.016025641025641024,
        0.015973630831643,
        0.015924741760944418,
        0.01559109080525414,
        0.01546451914098973,
        0.015386343216531895,
        0.015339578454332554,
        0.015219907407407408,
        0.01509627435342372
    ]
}